Target Of Traditional Chinese Medicine Triptolide Found | January 31, 2011 Issue - Vol. 89 Issue 5 | Chemical & Engineering News
Volume 89 Issue 5 | p. 45 | Concentrates
Issue Date: January 31, 2011

Target Of Traditional Chinese Medicine Triptolide Found

Uncovering natural product’s cellular target will facilitate the design of new anticancer and other drug leads
Department: Science & Technology
Keywords: cancer, triptolide, natural product, traditional Chinese medicine
8905sciconTrip_live-2
 

The biological target of the natural product triptolide, a traditional Chinese medicine now in human clinical trials, has been identified. The work by Jun O. Liu of Johns Hopkins University School of Medicine and coworkers could aid the design of triptolide analogs (Nat. Chem. Biol., DOI: 10.1038/nchembio.522). Found in a plant called lei gong teng, or thunder god vine, triptolide is a diterpene with an unusual structure containing three adjacent epoxide groups. It has been used for centuries to treat myriad medical conditions; has been shown to have anti-inflammatory, immunosuppressive, contraceptive, and antitumor activities; and is currently in human clinical trials for cancer and other disorders. Despite its history, triptolide’s cellular target has been unknown. Liu and coworkers now show that it binds to XPB, a subunit of TFIIH, a transcription factor that helps initiate RNA polymerase-based transcription and helps repair DNA damage. The discovery “will facilitate the design of new inhibitors of XPB and other homologous DNA helicases as anticancer and antiproliferative drug leads,” the researchers say.

 
Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment